EMPOWER

Stop & Shop Fights Pediatric Cancer with Kick Off of ‘Help Cure Childhood Cancer’ Campaign

Retrieved on: 
Thursday, February 29, 2024

Stop & Shop’s ‘Help Cure Childhood Cancer’ campaign will run in all stores from March 1 through March 31.

Key Points: 
  • Stop & Shop’s ‘Help Cure Childhood Cancer’ campaign will run in all stores from March 1 through March 31.
  • 100% of proceeds will benefit the two hospitals to assist in their pioneering pediatric cancer treatment and care.
  • The Stop & Shop Pediatric Brain Tumor Clinic at Dana-Farber Cancer Institute is a world-renowned destination for children with malignant and non-malignant brain tumors.
  • “Stop & Shop’s dedication and generous support of pediatric cancer continues to help fund critical research and care,” said Scott Armstrong, MD, PhD, chair of the Department of Pediatric Oncology at Dana-Farber Cancer Institute.

JARDIANCE Market Size, Forecast, and Emerging Insights, 2019-2023 and 2024-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom, and Japan - ResearchAndMarkets.com

Retrieved on: 
Friday, March 1, 2024

Further, it also consists of future market assessments inclusive of the JARDIANCE market forecast analysis for myocardial infarction in the 7MM, SWOT, analysts' views, comprehensive overview of market competitors, and brief about other emerging therapies in myocardial infarction.

Key Points: 
  • Further, it also consists of future market assessments inclusive of the JARDIANCE market forecast analysis for myocardial infarction in the 7MM, SWOT, analysts' views, comprehensive overview of market competitors, and brief about other emerging therapies in myocardial infarction.
  • JARDIANCE (Empagliflozin) is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily responsible for glucose re-absorption in the kidney.
  • The report also highlights the JARDIANCE research and development activities in myocardial infarction across the United States, Europe and Japan.
  • A detailed description of regulatory milestones, and developmental activities, provide the current development scenario of JARDIANCE in myocardial infarction.

BGE Awards ICF $65 Million in Energy Efficiency Contracts

Retrieved on: 
Tuesday, March 5, 2024

RESTON, Va., March 5, 2024 /PRNewswire/ -- Baltimore Gas and Electric (BGE) has awarded global consulting and technology services provider ICF (NASDAQ:ICFI) over $65 million in re-compete and new contracts to implement EmPOWER Maryland, the utility's statewide energy efficiency and demand response program. The agreements were awarded in the fourth quarter of 2024 and have a term of three years.

Key Points: 
  • RESTON, Va., March 5, 2024 /PRNewswire/ -- Baltimore Gas and Electric (BGE) has awarded global consulting and technology services provider ICF (NASDAQ:ICFI) over $65 million in re-compete and new contracts to implement EmPOWER Maryland, the utility's statewide energy efficiency and demand response program.
  • ICF has delivered award-winning energy efficiency programs for BGE for over 15 years that have achieved over 5.5 gigawatts in energy savings to over 18 million utility customers.
  • "We are excited to continue our longstanding work with BGE to evolve and optimize their energy efficiency programs as they navigate the challenging transition to a clean energy future," said Anne Choate, ICF executive vice president for energy, environment and infrastructure.
  • Read more about ICF's energy efficiency and technology services and how they help clients meet their electrification and decarbonization goals.

EMPOWER Leads Foster Care Services for All Children and Families in the Metroplex East Region

Retrieved on: 
Friday, March 1, 2024

DALLAS, March 1, 2024 /PRNewswire/ -- EMPOWER, a nonprofit child welfare collaborative, now provides foster care case management, kinship and reunification services for all children and families in the Metroplex East region, after entering Stage II of the Community-Based Care (CBC) contract with the State of Texas on March 1, 2024. EMPOWER is led by Texas Family Initiative LLC (TFI) and is supported by local providers in North Texas, including CK Family Services, Jonathan's Place, The Bair Foundation and Pathways Youth and Family Services. EMPOWER will serve as the lead agency for the nine-county area that includes Dallas, Collin, Ellis, Fannin, Grayson, Hunt, Rockwall, Kaufman and Navarro counties.

Key Points: 
  • CBC is an innovative approach to traditional foster care services because it utilizes local nonprofits to outsource out of home placement and case management services.
  • Since September 1, 2023, EMPOWER has provided placement services in the Metroplex East Region.
  • For the first time in over five years, all children in the Metroplex East Region are placed in licensed placements.
  • Around 79% of those foster children were placed within the same Metroplex East region, and 37.8% were placed in their home county.

The Family Initiative (TFI) Becomes One of the Largest Community-Based Care Child Welfare Agencies in the U.S.

Retrieved on: 
Friday, March 1, 2024

Currently, the organization provides programming across the U.S. focused on strengthening children and families and creating stronger, healthier communities.

Key Points: 
  • Currently, the organization provides programming across the U.S. focused on strengthening children and families and creating stronger, healthier communities.
  • TFI's programs include foster and kinship care, adoption, behavioral health, clinical and prevention services, residential, placement and case management services, administrative services, and child welfare software services in nine different states.
  • Overall, TFI holds four CBC foster care case management contracts, and two family preservation contracts in Kansas.
  • TFI is also a founding member of the newly formed National Center on Community-Based Child Welfare, a resource that will be available to other child welfare agencies.

Chemical Insights Research Institute Scientist Honored for Technical Innovation and STEM Education

Retrieved on: 
Monday, February 12, 2024

Dr. Christa Wright of Chemical Insights Research Institute (CIRI) of UL Research Institutes, will receive the Outstanding Technical Contribution in Industry Award at the 2024 Black Engineer of the Year Award (BEYA) STEM (science, technology, engineering and mathematics) Conference on Feb 17, 2024, in Baltimore, Md.

Key Points: 
  • Dr. Christa Wright of Chemical Insights Research Institute (CIRI) of UL Research Institutes, will receive the Outstanding Technical Contribution in Industry Award at the 2024 Black Engineer of the Year Award (BEYA) STEM (science, technology, engineering and mathematics) Conference on Feb 17, 2024, in Baltimore, Md.
  • She earned a Ph.D. in Environmental Systems and Environmental Toxicology and a Masters in Cancer Biology from North Carolina A&T State University.
  • Dr. Wright developed and led a National Institute of Environmental Health Sciences funded STEM summer program, called EMPOWER from 2018-2021 during her tenure at Georgia State University.
  • “Christa is extremely passionate about STEM education and research,” said Dr. Marilyn Black, Vice President and Senior Technical Advisor at CIRI.

Cardiac Dimensions Appoints Satya Shreenivas, MD as Chief Medical Officer

Retrieved on: 
Tuesday, January 16, 2024

Cardiac Dimensions ®, a leader in the development of innovative and minimally invasive treatment modalities to address patients suffering from heart failure with functional mitral regurgitation (FMR), today announced that renowned interventional cardiologist Satya Shreenivas, MD, MBA has joined the company as Chief Medical Officer.

Key Points: 
  • Cardiac Dimensions ®, a leader in the development of innovative and minimally invasive treatment modalities to address patients suffering from heart failure with functional mitral regurgitation (FMR), today announced that renowned interventional cardiologist Satya Shreenivas, MD, MBA has joined the company as Chief Medical Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240116766817/en/
    Cardiac Dimensions' new Chief Medical Officer Satya Shreenivas, MD, MBA (Photo: Business Wire)
    Dr. Shreenivas brings his rich experience in both the clinical and commercial aspects of the structural heart landscape to his new role with Cardiac Dimensions.
  • His industry roles have included serving as Chief Medical Officer for HLT Medical, a transcatheter heart valve company, as Chief of Cardiology with Optum/United Health subsidiary SCA Health, and as Medical Director for clinical research organization Medpace.
  • Dr. Shreenivas has been instrumental in advising Cardiac Dimensions on its EMPOWER Trial of the Carillon Mitral Contour System®.

DotLab announces top-tier, global pharmaceutical research clients for its DotEndo™ platform

Retrieved on: 
Monday, January 8, 2024

NEW YORK, Jan. 8, 2024 /PRNewswire/ -- DotLab, a medical diagnostics company, announced top-tier pharmaceutical research clients for its DotEndo™ platform.

Key Points: 
  • NEW YORK, Jan. 8, 2024 /PRNewswire/ -- DotLab, a medical diagnostics company, announced top-tier pharmaceutical research clients for its DotEndo™ platform.
  • The customers include global companies with interests in diagnosing or monitoring endometriosis on a Research Use Only basis in clinical trial subjects to support the development of new medicines.
  • "We're proud to share the news of our global pharmaceutical partners, which are complementary to our planned, large clinical offering for commercial endometriosis tests based on our technologies," said DotLab's founder, Heather Bowerman.
  • "We intend to continue to offer our pharma clients – and, ultimately, clinicians – a comprehensive endometriosis menu of tests and tools.

BMO Earns "Outstanding" Rating for its Community Reinvestment Act Performance

Retrieved on: 
Tuesday, December 12, 2023

CHICAGO, Dec. 12, 2023 /PRNewswire/ - BMO today announced it has received an overall rating of Outstanding from the Office of the Comptroller of the Currency (OCC) for its Community Reinvestment Act (CRA) Performance Evaluation.

Key Points: 
  • CHICAGO, Dec. 12, 2023 /PRNewswire/ - BMO today announced it has received an overall rating of Outstanding from the Office of the Comptroller of the Currency (OCC) for its Community Reinvestment Act (CRA) Performance Evaluation.
  • Over the past 10 years, fewer than 10 percent of banks received a CRA rating of Outstanding, the highest possible rating.
  • This is the third consecutive time BMO has earned an Outstanding rating in the evaluation.
  • We will continue to prioritize community reinvestment, working closely with our local partners and stakeholders, driving progress for a more equitable future."

Gilbane Building Company Promotes Heidi DeBenedetti to Chief Operating Officer

Retrieved on: 
Wednesday, December 6, 2023

PROVIDENCE, R.I., Dec. 6, 2023 /PRNewswire-PRWeb/ -- Gilbane Building Company announced today that Heidi DeBenedetti will be promoted to chief operating officer (COO) effective January 1, 2024, making her one of the construction industry's top women executive leaders. DeBenedetti, who previously served as regional president and chief administrative officer, comes to the position with 25 years of industry experience – nine of which are with Gilbane.

Key Points: 
  • PROVIDENCE, R.I., Dec. 6, 2023 /PRNewswire-PRWeb/ -- Gilbane Building Company announced today that Heidi DeBenedetti will be promoted to chief operating officer (COO) effective January 1, 2024, making her one of the construction industry's top women executive leaders.
  • "Heidi's ability to develop high-performing teams, build operational excellence, and lead complex projects is invaluable," said Adam R. Jelen, Gilbane Building Company's chief operating officer and incoming chief executive officer.
  • "Heidi's ability to develop high-performing teams, build operational excellence, and lead complex projects is invaluable," said Adam R. Jelen, Gilbane Building Company's chief operating officer and incoming chief executive officer.
  • "As our chief operating officer, she will be integral to positioning Gilbane for future growth while supporting a workplace culture that thrives on innovation, talent development, and inclusion.